We are analyzing https://link.springer.com/article/10.1007/bf01807363.

Title:
Biological differences among MCF-7 human breast cancer cell lines from different laboratories | Breast Cancer Research and Treatment
Description:
MCF-7 human breast cancer cells are used widely for studies of tumor biology and hormone mechanism of action. Conflicting results have often been obtained in studies reported from different laboratories. In this report several biological properties were studied in four MCF-7 cell lines obtained from different laboratories. MCF-7 (ATCC), MCF-7, MCF-7 (KO), and MCF-7 (S) demonstrated similar morphology in monolayer culture. Chromosome analysis revealed that three of the lines shared several structural chromosome alterations and marker chromsomes; however, MCF-7 (ATCC) was distinctly different with virtually no chromosomal alterations shared in common with the other lines. All four lines contained variable amounts of estrogen receptor (ER) and progesterone receptor (PgR). The growth rate of MCF-7 (ATCC) was 50% slower than that of the other lines, and, unlike the other three lines, cell proliferation was unaffected by estrogen or antiestrogen treatment despite the presence of receptors. Cloning efficiency of the four lines varied over a 10-fold range. Tumorigenicity in athymic nude mice also varied considerably among these lines. MCF-7 (ATCC) grew well in ovariectomized nude mice, while the other lines required estrogen supplementation. MCF-7 (S) and MCF-7 grew rapidly with estrogen supplementation; MCF-7 (KO) grew very slowly. Antiestrogen therapy inhibited growth of MCF-7, MCF-7 (S), and MCF-7 (KO) tumors, but it had no effect on MCF-7 (ATCC). These data demonstrate that MCF-7 lines from different laboratories may have unique biological properties, despite having a similar karyotype (MCF-7, MCF-7 (S), MCF-7 (KO)). The fundamental differences in karyotype and biological properties of the MCF-7 (ATCC), and the previously reported differences in DNA restriction fragment polymorphism analyses, demonstrate that this line is derived from an entirely different patient. Investigators should carefully document the source and identity of MCF-7 cells used in published experiments.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cancer, mcf, breast, google, scholar, human, pubmed, cell, res, lines, cells, estrogen, growth, article, osborne, culture, receptor, line, trent, atcc, privacy, cookies, research, biological, laboratories, effect, estrogens, content, analysis, data, publish, search, differences, hobbs, antiestrogen, nude, mice, access, mcguire, effects, tissue, usa, processing, information, log, journal, treatment, studies, properties, chromosome,

Topics {✒️}

month download article/chapter human cell line cloning efficiency long-term tissue culture human breast cancer athymic nude mice ovariectomized nude mice cell line mcf-7 direct growth-stimulating effect estrogen-responsive cell chromosome analysis revealed chromosome banding analysis privacy choices/manage cookies restriction fragment polymorphisms tissue culture media human cytogenetic nomenclature breast cancer full article pdf epidermal growth factor european economic area scope submit manuscript structural chromosome alterations plasminogen activator activity de la garza breast carcinoma conditions privacy policy demonstrated similar morphology chromosomal alterations shared low serum concentration mcf-7 cells pleural effusion derived derived variant sublines previously reported differences cell genetics 21 accepting optional cookies usage analysis check access vitro model systems instant access unique biological properties cell proliferation similar karyotype mammalian cells estrogen receptor level estrogen receptor assays mcf-7 grew rapidly journal finder publish kent osborne cancer res 38 cancer res 44

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Biological differences among MCF-7 human breast cancer cell lines from different laboratories
         description:MCF-7 human breast cancer cells are used widely for studies of tumor biology and hormone mechanism of action. Conflicting results have often been obtained in studies reported from different laboratories. In this report several biological properties were studied in four MCF-7 cell lines obtained from different laboratories. MCF-7 (ATCC), MCF-7, MCF-7 (KO), and MCF-7 (S) demonstrated similar morphology in monolayer culture. Chromosome analysis revealed that three of the lines shared several structural chromosome alterations and marker chromsomes; however, MCF-7 (ATCC) was distinctly different with virtually no chromosomal alterations shared in common with the other lines. All four lines contained variable amounts of estrogen receptor (ER) and progesterone receptor (PgR). The growth rate of MCF-7 (ATCC) was 50% slower than that of the other lines, and, unlike the other three lines, cell proliferation was unaffected by estrogen or antiestrogen treatment despite the presence of receptors. Cloning efficiency of the four lines varied over a 10-fold range. Tumorigenicity in athymic nude mice also varied considerably among these lines. MCF-7 (ATCC) grew well in ovariectomized nude mice, while the other lines required estrogen supplementation. MCF-7 (S) and MCF-7 grew rapidly with estrogen supplementation; MCF-7 (KO) grew very slowly. Antiestrogen therapy inhibited growth of MCF-7, MCF-7 (S), and MCF-7 (KO) tumors, but it had no effect on MCF-7 (ATCC). These data demonstrate that MCF-7 lines from different laboratories may have unique biological properties, despite having a similar karyotype (MCF-7, MCF-7 (S), MCF-7 (KO)). The fundamental differences in karyotype and biological properties of the MCF-7 (ATCC), and the previously reported differences in DNA restriction fragment polymorphism analyses, demonstrate that this line is derived from an entirely different patient. Investigators should carefully document the source and identity of MCF-7 cells used in published experiments.
         datePublished:
         dateModified:
         pageStart:111
         pageEnd:121
         sameAs:https://doi.org/10.1007/BF01807363
         keywords:
            breast cancer
            cloning efficiency
            karyotype
            MCF-7 cells
            nude mice
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Martinus Nijhoff/Dr. W. Junk Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:C. Kent Osborne
               affiliation:
                     name:The University of Texas Health Science Center at San Antonio
                     address:
                        name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kimberly Hobbs
               affiliation:
                     name:The University of Texas Health Science Center at San Antonio
                     address:
                        name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeffrey M. Trent
               affiliation:
                     name:University of Arizona Health Sciences Center
                     address:
                        name:Cancer Center, University of Arizona Health Sciences Center, Tucson, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Biological differences among MCF-7 human breast cancer cell lines from different laboratories
      description:MCF-7 human breast cancer cells are used widely for studies of tumor biology and hormone mechanism of action. Conflicting results have often been obtained in studies reported from different laboratories. In this report several biological properties were studied in four MCF-7 cell lines obtained from different laboratories. MCF-7 (ATCC), MCF-7, MCF-7 (KO), and MCF-7 (S) demonstrated similar morphology in monolayer culture. Chromosome analysis revealed that three of the lines shared several structural chromosome alterations and marker chromsomes; however, MCF-7 (ATCC) was distinctly different with virtually no chromosomal alterations shared in common with the other lines. All four lines contained variable amounts of estrogen receptor (ER) and progesterone receptor (PgR). The growth rate of MCF-7 (ATCC) was 50% slower than that of the other lines, and, unlike the other three lines, cell proliferation was unaffected by estrogen or antiestrogen treatment despite the presence of receptors. Cloning efficiency of the four lines varied over a 10-fold range. Tumorigenicity in athymic nude mice also varied considerably among these lines. MCF-7 (ATCC) grew well in ovariectomized nude mice, while the other lines required estrogen supplementation. MCF-7 (S) and MCF-7 grew rapidly with estrogen supplementation; MCF-7 (KO) grew very slowly. Antiestrogen therapy inhibited growth of MCF-7, MCF-7 (S), and MCF-7 (KO) tumors, but it had no effect on MCF-7 (ATCC). These data demonstrate that MCF-7 lines from different laboratories may have unique biological properties, despite having a similar karyotype (MCF-7, MCF-7 (S), MCF-7 (KO)). The fundamental differences in karyotype and biological properties of the MCF-7 (ATCC), and the previously reported differences in DNA restriction fragment polymorphism analyses, demonstrate that this line is derived from an entirely different patient. Investigators should carefully document the source and identity of MCF-7 cells used in published experiments.
      datePublished:
      dateModified:
      pageStart:111
      pageEnd:121
      sameAs:https://doi.org/10.1007/BF01807363
      keywords:
         breast cancer
         cloning efficiency
         karyotype
         MCF-7 cells
         nude mice
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Martinus Nijhoff/Dr. W. Junk Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:C. Kent Osborne
            affiliation:
                  name:The University of Texas Health Science Center at San Antonio
                  address:
                     name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kimberly Hobbs
            affiliation:
                  name:The University of Texas Health Science Center at San Antonio
                  address:
                     name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeffrey M. Trent
            affiliation:
                  name:University of Arizona Health Sciences Center
                  address:
                     name:Cancer Center, University of Arizona Health Sciences Center, Tucson, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:9
Organization:
      name:Martinus Nijhoff/Dr. W. Junk Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Texas Health Science Center at San Antonio
      address:
         name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
         type:PostalAddress
      name:The University of Texas Health Science Center at San Antonio
      address:
         name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
         type:PostalAddress
      name:University of Arizona Health Sciences Center
      address:
         name:Cancer Center, University of Arizona Health Sciences Center, Tucson, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:C. Kent Osborne
      affiliation:
            name:The University of Texas Health Science Center at San Antonio
            address:
               name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
               type:PostalAddress
            type:Organization
      name:Kimberly Hobbs
      affiliation:
            name:The University of Texas Health Science Center at San Antonio
            address:
               name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
               type:PostalAddress
            type:Organization
      name:Jeffrey M. Trent
      affiliation:
            name:University of Arizona Health Sciences Center
            address:
               name:Cancer Center, University of Arizona Health Sciences Center, Tucson, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
      name:Department of Medicine Division of Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
      name:Cancer Center, University of Arizona Health Sciences Center, Tucson, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(82)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.36s.

LINK . SPRINGER . COM {}